Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics. 2002;110:1182-92.

Min MO, Minnes S, Lang A, Weishampel P, Short EJ, Yoon S. Externalizing behavior and substance use related problems at 15 years in prenatally cocaine exposed adolescents. J Adolesc. 2014;37:269.

Richardson GA, Goldschmidt L, Larkby C, Day NL. Effects of prenatal cocaine exposure on child behavior and growth at 10 years of age. Neurotoxicol Teratol. 2013;40:1-8.

Meyer KD, Zhang L. Short- and long-term adverse effects of cocaine abuse during pregnancy on the heart development. Ther Adv Cardiovasc Dis. 2009;3:7-16.

LaGasse LL, Gaskins RB, Bada HS, Shankaran S, Liu J, Lester BM. Prenatal cocaine exposure and childhood obesity at nine years. Neurotoxicol Teratol. 2011;33:188-97.

Shankaran S, Bann CM, Bauer CR, Lester BM, Bada HS, Das A. Prenatal cocaine exposure and BMI and blood pressure at 9 years of age. J Hypertens. 2010;28:1166-75.

Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-7.

Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4-7.

Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-95.

Kiecolt-Glaser JK, Gouin JP, Hantsoo L. Close relationships, inflammation, and health. Neurosci Biobehav Rev. 2010;35:33-8.

Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-43.

Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117:1175-83.

Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27:813-23.

Tian R, Hou G, Li D, Yuan TF. A possible change process of inflammatory cytokines in the prolonged chronic stress and its ultimate implications for health. ScientificWorldJournal. 2014;2014:780616.

Sinha R. How does stress increase risk of drug abuse and relapse. Psychopharmacology (Berl). 2001;158:343-59.

Fox HC, D'Sa C, Kimmerling A, Siedlarz KM, Tuit KL, Stowe R. Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum Psychopharmacol. 2012;27:156-66.

Narvaez JC, Magalhães PV, Fries GR, Colpo GD, Czepielewski LS, Vianna P. Peripheral toxicity in crack cocaine use disorders. Neurosci Lett. 2013;544:80-4.

De Giovanni N, Marchetti D. Cocaine and its metabolites in the placenta: a systematic review of the literature. Reprod Toxicol. 2012;33:1-14.

Riezzo I, Fiore C, De Carlo D, Pascale N, Neri M, Turillazzi E. Side effects of cocaine abuse: multiorgan toxicity and pathological consequences. Curr Med Chem. 2012;19:5624-46.

Eiden RD, Veira Y, Granger DA. Prenatal cocaine exposure and infant cortisol reactivity. Child Dev. 2009;80:528-43.

Brown JV, Bakeman R, Coles CD, Platzman KA, Lynch ME. Prenatal cocaine exposure: a comparison of 2-year-old children in parental and nonparental care. Child Dev. 2004;75:1282-95.

Karlix JL, Behnke M, Davis-Eyler F, Wobie K, Adams V, Freiburger B. Cocaine suppresses fetal immune system. Pediatr Res. 1998;44:43-6.

Diesner SC, Förster-Waldl E, Olivera A, Pollak A, Jensen-Jarolim E, Untersmayr E. Perspectives on immunomodulation early in life. Pediatr Allergy Immunol. 2012;23:210-23.

Chatterjee P, Chiasson VL, Bounds KR, Mitchell BM. Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy. Front Immunol. 2014;5:253.

NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration. 2013.

Nascimento do E, Figueiredo de VLM. WISC-III e WAIS-III: alterações nas versões originais americanas decorrentes das adaptações para uso no Brasil. Psicol Reflex Crit. 2002;15:603-12.

Wechsler D. WAIS-III - Escala de inteligência Wechsler para adultos. 2004.

Amorim P. Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras Psiquiatr. 2000;22:106-15.

Henrique IF, De Micheli D, Lacerda RB, Lacerda LA, Formigoni ML. [Validation of the Brazilian version of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)]. Rev Assoc Med Bras. 2004;50:199.

Szobot CM, Rohde LA, Bukstein O, Molina BS, Martins C, Ruaro P. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study. Addiction. 2007;102:1122-30.

Mattar FN. Análise crítica dos estudos de estratificação sócio-econômicada ABA-Abipeme. Rev Adm. 1995;30:57-74.

Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med. 2012;42:1321-8.

Hermida-Ameijeiras A, Méndez-Alvarez E, Sánchez-Iglesias S, Sanmartín-Suárez C, Soto-Otero R. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem Int. 2004;45:103-16.

Smythies J, Galzigna L. The oxidative metabolism of catecholamines in the brain: a review. Biochim Biophys Acta. 1998;1380:159-62.

Vaziri ND. Causal link between oxidative stress, inflammation, and hypertension. Iran J Kidney Dis. 2008;2:1-10.

Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37:137-62.

Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009;29:247-64.

Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol. 2006;6:318-28.

Leckman JF. Commentary: What does immunology have to do with brain development and psychopathology?--a commentary on O'Connor et al. (2014). J Child Psychol Psychiatry. 2014;55:632-4.

O'Connor TG, Moynihan JA, Caserta MT. Annual research review: the neuroinflammation hypothesis for stress and psychopathology in children--developmental psychoneuroimmunology. J Child Psychol Psychiatry. 2014;55:615-31.

Glover V. Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms. Adv Neurobiol. 2015;10:269-83.

Cheng CY, Pickler RH. Perinatal stress, fatigue, depressive symptoms, and immune modulation in late pregnancy and one month postpartum. ScientificWorldJournal. 2014;2014:652630.

Coussons-Read ME, Okun ML, Nettles CD. Psychosocial stress increases inflammatory markers and alters cytokine production across pregnancy. Brain Behav Immun. 2007;21:343-50.

Ruiz RJ, Fullerton J, Dudley DJ. The interrelationship of maternal stress, endocrine factors and inflammation on gestational length. Obstet Gynecol Surv. 2003;58:415-28.

Delaney-Black V, Covington C, Nordstrom B, Ager J, Janisse J, Hannigan JH. Prenatal cocaine: quantity of exposure and gender moderation. J Dev Behav Pediatr. 2004;25:254-63.

Nordstrom Bailey B, Sood BG, Sokol RJ, Ager J, Janisse J, Hannigan JH. Gender and alcohol moderate prenatal cocaine effects on teacher-report of child behavior. Neurotoxicol Teratol. 2005;27:181-9.

Kiecolt-Glaser JK, Gouin JP, Weng NP, Malarkey WB, Beversdorf DQ, Glaser R. Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom Med. 2011;73:16-22.

Lester BM, Padbury JF. Third pathophysiology of prenatal cocaine exposure. Dev Neurosci. 2009;31:23-35.

Tyrka AR, Burgers DE, Philip NS, Price LH, Carpenter LL. The neurobiological correlates of childhood adversity and implications for treatment. Acta Psychiatr Scand. 2013;128:434-47.

Sadri-Vakili G. Cocaine triggers epigenetic alterations in the corticostriatal circuit. Brain Res. 2015;1628:50-9.

Baune BT, Konrad C, Grotegerd D, Suslow T, Birosova E, Ohrmann P. Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. J Neuroinflammation. 2012;9:125.

Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry. 2008;64:484-90.

Bandstra ES, Morrow CE, Vogel AL, Fifer RC, Ofir AY, Dausa AT. Longitudinal influence of prenatal cocaine exposure on child language functioning. Neurotoxicol Teratol. 2002;24:297-308.

Delaney-Black V, Covington C, Templin T, Kershaw T, Nordstrom-Klee B, Ager J. Expressive language development of children exposed to cocaine prenatally: literature review and report of a prospective cohort study. J Commun Disord. 2000;33:463-81.

Eyler FD, Behnke M, Conlon M, Woods NS, Wobie K. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment. Pediatrics. 1998;101:237-41.

Potter SM, Zelazo PR, Stack DM, Papageorgiou AN. Adverse effects of fetal cocaine exposure on neonatal auditory information processing. Pediatrics. 2000;105:E40.

Singer LT, Arendt R, Minnes S, Farkas K, Salvator A, Kirchner HL. Cognitive and motor outcomes of cocaine-exposed infants. JAMA. 2002;287:1952-60.

Baraban SC, Schwartzkroin PA. Effects of prenatal cocaine exposure on the developing hippocampus: intrinsic and synaptic physiology. J Neurophysiol. 1997;77:126-36.

Chaudhry IB, Hallak J, Husain N, Minhas F, Stirling J, Richardson P. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol. 2012;26:1185-93.

Lotrich FE, Sears B, McNamara RK. Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6. Brain Behav Immun. 2013;31:48-53.

Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry. 2012;37:222-6.

Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31-41.

Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH. Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology. 2010;35:2617-23.

Mesquita AR, Correia-Neves M, Roque S, Castro AG, Vieira P, Pedrosa J. IL-10 modulates depressive-like behavior. J Psychiatr Res. 2008;43:89-97.

Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry. 2008;13:208-21.

Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry. 2012;2:e199.